跳至主要内容
临床试验/IRCT20200928048862N1
IRCT20200928048862N1已完成1 期

The effect of duloxetine in quality of life and symptoms of patients with irritable bowel syndrome (IBS)

Iran University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with irritable bowel syndrome (IBS)
  • Mild to moderate score (score less than 11) in the Anxiety and Depression Questionnaire.

排除标准

  • Psychotic patients, bipolar disorder, obsessive-compulsive disorder, substance use in the last 6 months, dementia, suicidal idea
  • Taking psychotropic drugs in the last 2 weeks
  • Pregnancy and lactation
  • age of under 18 years old and over 65 years old
  • digestive bleeding
  • Persistent vomiting
  • Persistent abdominal pain
  • Unexplained weight loss
  • Crohn's, celiac disease, colon cancer, seizures, hypertension, angle-closure glaucoma,

研究者

相似试验